Zymeworks Inc. Form 8-K Summary
Business Context and Reporting Date
Zymeworks Inc. filed a Current Report on Form 8-K dated December 16, 2022, reporting the results of its 2022 annual meeting of stockholders held on December 16, 2022. The report was signed and filed on December 19, 2022.
The filing concerns corporate governance matters and does not provide quarterly or annual financial results.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
As of the November 15, 2022 record date, 63,003,370 common shares and 1,424,533 exchangeable shares were entitled to vote. Shares represented at the meeting constituted approximately 55.74% of voting power, establishing a quorum.
Meeting Results and Material Changes
- Director elections: Troy M. Cox, Kenneth Hillan, and Natalie Sacks were elected to serve until their terms expire or successors are elected or appointed.
- Executive compensation: Securityholders approved, on an advisory and non-binding basis, the compensation of the named executive officers. Votes were 25,486,721 for, 4,485,962 against, and 44,393 abstaining.
- Auditor ratification: Securityholders ratified the appointment of KPMG LLP as the Company’s auditor for the year ending December 31, 2022. Votes were 35,682,260 for, 177,422 against, and 54,832 abstaining.
| Director | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Troy M. Cox | 19,442,093 | 10,574,983 | 5,897,438 |
| Kenneth Hillan | 21,670,332 | 8,346,744 | 5,897,438 |
| Natalie Sacks | 21,752,839 | 8,264,237 | 5,897,438 |
Guidance, Risks, and Unusual Items
The filing contains no financial guidance, operational outlook, risk updates, contingencies, or unusual accounting items. The executive compensation vote was advisory and non-binding.
Key Facts to Verify
- Confirm the composition and continuing tenure of the three elected directors.
- Review the Company’s proxy statement dated November 25, 2022 for the detailed proposals and director information.
- Assess the subsequent financial statements for the year ended December 31, 2022, including the results of the ratified KPMG audit.
- Monitor future filings for any governance, compensation, or shareholder matters arising after the annual meeting.